Overactivation of the PI3K/mTOR pathway - through the presence of activating mutations (e.g. in PIK3CA), loss of the negative regulator PTEN, and/or activation of upstream receptor tyrosine kinase receptor signaling - underlies tumor growth and is a key oncogenic driver in most human cancers, including gliomas. This evidence concerns the gene PIK3CA and cancer.